{"product_id":"opdivo-40mg-injection","title":"Opdivo  40mg Injection","description":"\u003cdiv class=\"flex-shrink-0 flex flex-col relative items-end\"\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv class=\"pt-0\"\u003e\r\n\u003cdiv class=\"gizmo-bot-avatar flex h-8 w-8 items-center justify-center overflow-hidden rounded-full\"\u003e\r\n\u003cdiv class=\"relative p-1 rounded-sm flex items-center justify-center bg-token-main-surface-primary text-token-text-primary h-8 w-8\"\u003e\u003cspan style=\"color: #333333; font-family: 'Open Sans', 'Helvetica Neue', Helvetica, Arial, sans-serif; font-size: 18px; font-weight: 600;\"\u003eNivolumab Drug Description\u003c\/span\u003e\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv class=\"group\/conversation-turn relative flex w-full min-w-0 flex-col agent-turn\"\u003e\r\n\u003cdiv class=\"flex-col gap-1 md:gap-3\"\u003e\r\n\u003cdiv class=\"flex max-w-full flex-col flex-grow\"\u003e\r\n\u003cdiv class=\"min-h-[20px] text-message flex w-full flex-col items-end gap-2 break-words [.text-message+\u0026amp;]:mt-5 overflow-x-auto whitespace-pre-wrap\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"5b878aad-893f-4fc0-901e-8b44a7636eda\"\u003e\r\n\u003cdiv class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[3px]\"\u003e\r\n\u003cp class=\"markdown prose w-full break-words dark:prose-invert dark\"\u003e\u003cstrong\u003eDrug Class and Categories:\u003c\/strong\u003e Nivolumab belongs to the class of \u003cstrong\u003eimmunotherapy\u003c\/strong\u003e agents and is categorized as a \u003cstrong\u003emonoclonal antibody\u003c\/strong\u003e. It is used in the field of \u003cstrong\u003eoncology\u003c\/strong\u003e to treat various types of cancers.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eActive Ingredient and Other Names:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eActive Ingredient:\u003c\/strong\u003e Nivolumab\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003ePopular and Other Names:\u003c\/strong\u003e Opdivo (brand name), Nivolumab Injection\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cstrong\u003eMode of Action:\u003c\/strong\u003e Nivolumab works by blocking the PD-1 (programmed death-1) receptor on immune cells. PD-1 is a checkpoint protein that inhibits immune responses against cancer cells. By inhibiting PD-1, Nivolumab enhances the immune system's ability to recognize and attack cancer cells, thus improving the body’s immune response to tumors.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eHow to Use It:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eAdministration:\u003c\/strong\u003e Nivolumab is administered via intravenous infusion.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eUsage:\u003c\/strong\u003e Infusions are typically given in a clinical setting, usually every 2 to 4 weeks, depending on the type of cancer and individual treatment plan.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cstrong\u003eRecommended Dosage:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eNon-Small Cell Lung Cancer (NSCLC):\u003c\/strong\u003e 240 mg every 2 weeks or 480 mg every 4 weeks.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eMelanoma:\u003c\/strong\u003e 240 mg every 2 weeks or 480 mg every 4 weeks.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eRenal Cell Carcinoma:\u003c\/strong\u003e 240 mg every 2 weeks or 480 mg every 4 weeks.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eHodgkin Lymphoma:\u003c\/strong\u003e 240 mg every 2 weeks.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eOther Cancers:\u003c\/strong\u003e Dosage may vary based on specific cancer type and treatment response.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cstrong\u003eDirections:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eInfusion Protocol:\u003c\/strong\u003e Administer Nivolumab as an intravenous infusion over a period of 30 minutes.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003ePreparation:\u003c\/strong\u003e Follow the guidelines for preparation and dilution provided by the manufacturer. Ensure all equipment and infusion procedures are sterile.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cstrong\u003eCautions:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003ePregnancy and Breastfeeding:\u003c\/strong\u003e Use Nivolumab with caution if pregnant or breastfeeding. Consult with your healthcare provider about the risks and benefits.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003ePre-existing Conditions:\u003c\/strong\u003e Inform your healthcare provider about any history of autoimmune diseases, organ transplants, or infections.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eImmune-Related Adverse Events:\u003c\/strong\u003e Monitor for signs of immune-related adverse effects, such as pneumonitis, colitis, hepatitis, endocrinopathies, and nephritis.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cstrong\u003eManage Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e Fatigue, rash, diarrhea, and nausea.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eSevere Side Effects:\u003c\/strong\u003e Seek immediate medical attention for symptoms of severe immune reactions, such as persistent cough, severe abdominal pain, jaundice, or signs of an allergic reaction.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cstrong\u003eGuidelines:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eStorage:\u003c\/strong\u003e Store Nivolumab in the refrigerator (2°C to 8°C). Do not freeze. Keep it in its original packaging to protect from light.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eMissed Dose:\u003c\/strong\u003e If a dose is missed, contact your healthcare provider to reschedule the infusion as soon as possible.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eOverdose:\u003c\/strong\u003e In case of overdose, seek emergency medical assistance. Monitor and manage adverse effects according to clinical guidelines.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cstrong\u003eFrequently Asked Questions (FAQs):\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003col\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eWhat is Nivolumab used for?\u003c\/strong\u003e\u003cbr\u003eNivolumab is used to treat various cancers including non-small cell lung cancer, melanoma, renal cell carcinoma, and Hodgkin lymphoma by enhancing the body's immune response against cancer cells.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eHow is Nivolumab administered?\u003c\/strong\u003e\u003cbr\u003eNivolumab is given as an intravenous infusion in a clinical setting. The infusion is typically administered every 2 to 4 weeks.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eWhat are the common side effects of Nivolumab?\u003c\/strong\u003e\u003cbr\u003eCommon side effects include fatigue, rash, diarrhea, and nausea. Severe immune-related adverse effects may also occur.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eWhat should I do if I miss a dose of Nivolumab?\u003c\/strong\u003e\u003cbr\u003eContact your healthcare provider immediately to reschedule the infusion. It is important to adhere to the treatment schedule.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eAre there any special precautions while using Nivolumab?\u003c\/strong\u003e\u003cbr\u003eYes, monitor for immune-related adverse effects and inform your healthcare provider about any pre-existing conditions or symptoms of severe reactions.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eCan Nivolumab be used in combination with other treatments?\u003c\/strong\u003e\u003cbr\u003eNivolumab can be used alone or in combination with other therapies, such as other checkpoint inhibitors or chemotherapy, depending on the cancer type and treatment plan.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51736491589915,"sku":"Generic Opdivo (Nivolumab) 40mg Injection","price":1032.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/ezchemist.com\/products\/opdivo-40mg-injection","provider":"EZ Chemist","version":"1.0","type":"link"}